Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02283307 · ClinicalTrials.gov registry record · NA
Dual Energy CT Urography With Reduced Iodinated Contrast
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02283307: Completed NA study, sponsored by University of Washington.
NCT02283307 is a NA study that has completed, run by University of Washington. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02283307, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
The goal of this study is to validate that Dual Energy CT (DECT) urography when performed with a 50% reduction in iodinated contrast dose results in a CT exam with equal or better image quality and equal or better diagnostic capability compared to traditional Single Energy CT (SECT) performed with a standard contrast dose.
Interventions
- OTHER Reduced contrast DECT scan
- OTHER Standard contrast SECT scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02283307 record still lists
NCT02283307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Reduced contrast DECT scan is the first listed.
NCT02283307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02283307 about?
NCT02283307 is a clinical study titled "Dual Energy CT Urography With Reduced Iodinated Contrast". The goal of this study is to validate that Dual Energy CT (DECT) urography when performed with a 50% reduction in iodinated contrast dose results in a CT exam with equal or better image quality and equal or better diagnostic capability compared to traditional Single Energy CT (SECT) performed with a...
What is the current status of trial NCT02283307?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-09. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02283307?
The interventions under investigation include: Reduced contrast DECT scan (OTHER), Standard contrast SECT scan (OTHER).
Who is sponsoring clinical trial NCT02283307?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02283307's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia